SAN DIEGO–(BUSINESS WIRE)–Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has completed its investigation reg… […]
SAN DIEGO–(BUSINESS WIRE)–Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has completed its investigation reg… […]
SAN DIEGO–(BUSINESS WIRE)–Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has completed its investigation reg… […]
SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary gene engineering platform technologies to create cell and gene therapeutics with the capacity to cur… […]
Trefoil Therapeutics believes the drug could improve vision in people who would otherwise need a corneal transplant […]
Trefoil Therapeutics believes the drug could improve vision in people who would otherwise need a corneal transplant […]
Trefoil Therapeutics believes the drug could improve vision in people who would otherwise need a corneal transplant […]
Custom audit rooms, browse-only document binders, and micro-securitized content for regulatory teams are provided in the platform for the current work-from-home, travel-restricted business climate
SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — Projecis, In… […]
– DelMar Pharmaceuticals, Inc. Name Change to Kintara Therapeutics, Inc.- Kintara Therapeutics to Trade on Nasdaq Capital Market under the Ticker Symbol “KTRA”
SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — Kintara Therapeutics, Inc. (formerly DelMar Pharm… […]
CARLSBAD, Calif., Aug. 20, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the United States Patent and Trademark Office has issued patent No. 10,744,257 entitled “Devices and Methods f… […]
Oral Presentation to Highlight New Efficacy Data Measured at Week 16 and Additional Week 12 Efficacy Data Stratified by Baseline Characteristics and Risk Factors
SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — Viking Therapeutics, Inc. (Viking) (NASDAQ: VKT… […]
Covistat repurposing generic pancreatitis remedy for oral, inhaled COVID-19 treatments
SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — A preclinical study testing the low-cost generic drug nafamostat in human cells shows it can help block SARS-CoV-2 infecti… […]
LA JOLLA, CA—Salk scientist Tony Hunter has received a National Cancer Institute (NCI) Outstanding Investigator Award (OIA), which supports accomplished leaders in cancer research. Hunter, who is an American Cancer Society Professor, will receive more … […]
LA JOLLA—Father of genetics Gregor Mendel spent years tediously observing and measuring pea plant traits by hand in the 1800s to uncover the basics of genetic inheritance. Today, botanists can track the traits, or phenotypes, of hundreds or thousands o… […]
LA JOLLA—Father of genetics Gregor Mendel spent years tediously observing and measuring pea plant traits by hand in the 1800s to uncover the basics of genetic inheritance. Today, botanists can track the traits, or phenotypes, of hundreds or thousands o… […]
LA JOLLA—Breast cancer is one of the most prevalent cancers, and some forms rank among the most difficult to treat. Its various types and involvement of many different cells makes targeting such tumors difficult. Now, Salk Institute researchers have us… […]
LA JOLLA—Salk Institute scientists have made a major advance in the pursuit of a safe and effective treatment for type 1 diabetes, an illness that impacts an estimated 1.6 million Americans with a cost of $14.4 billion annually.
The post First immune-e… […]
Lysulin’s claims are raising eyebrows and questions among local diabetes experts […]
The San Diego developer of targeted cancer drugs said the FDA might allow it to file for approval of repotrectinib sooner than previously expected. […]
SAN DIEGO–(BUSINESS WIRE)– #Infectiousdisease–The number of Americans afflicted with Lyme disease was found to be 10 times greater than the 30,000 cases reported each year by the CDC. […]
SAN DIEGO, Aug. 18, 2020 /PRNewswire/ — Inhibrx, Inc. (“Inhibrx”) (Nasdaq: INBX), a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates, today announced the pricing of its initial pub… […]
SAN DIEGO–(BUSINESS WIRE)– #California–Biocom announces endorsement of California Proposition 14, the Stem Cell Research Institute Bond Initiative. […]
Most of Novo Nordisk’s kidney work has come from diabetes, but eyeing an R&D expansion, the Danish giant is putting money down on a pact to target chronic kidney disease directly.
The new deal comes with an old partner: the German drug discovery co… […]
Expands Company’s patent portfolio and marks another step in pursuit of worldwide intellectual property protection for proprietary Primer-Switch technology used to detect rare events such as cancer biomarkers found in tissue and liquid biopsies
SAN … […]
Companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients who may benefit from pyrotinib
CARLSBAD, Calif., Aug. 17, 2020 /PRNewswire/ — Thermo Fisher Scientific has signed a companion diagnostic … […]
CARLSBAD, Calif., Aug. 14, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) today announced business highlights and financial results for the fiscal year 2021 first quarter, ended June 30, 2020.
Business hig… […]
Copyright © 2021 Biotech Networks, LLC
